PRIYANKA SHARMA, MD, a breast cancer medical oncologist at The University of Kansas Cancer Center, has been named Vice Chair of SWOG’s Breast Committee.
Priyanka Sharma, MD
SWOG, formerly the Southwest Oncology Group, is a global cancer research community that designs and conducts publicly funded clinical trials. It is one of five National Cancer Institute (NCI) National Clinical Trials Network–funded groups.
Dr. Sharma has been a member of SWOG’s Breast Committee since 2013. She is actively involved in both clinical and translational research at The University of Kansas Cancer Center. Improving treatment outcomes for aggressive breast cancer subtypes, including triple-negative breast cancer, is her main research focus. Dr. Sharma is the principal investigator of multiple investigator-initiated phase I/II clinical trials of novel targeted agents in triple-negative breast cancer.
About the SWOG Breast Committee
THE SWOG BREAST COMMITTEE comprises 244 members who share an interest in treating and conducting breast cancer clinical trials. As Vice Chair, Dr. Sharma’s responsibilities will include overseeing SWOG breast cancer research activities and developing new ideas for clinical research.
The SWOG Breast Committee Chair and Vice Chair are members of the NCI Breast Cancer Steering Committee, which reviews all breast cancer trials conducted through the National Clinical Trials Network.
In addition to her new Vice Chair role with SWOG, Sharma has been co-leading a project funded by the SWOG Integrated Translational Science Center program, which aims to facilitate incorporation of translational science into NCI-supported cancer clinical trials. ■
